Accessibility Menu
Ventripoint Diagnostics logo

Ventripoint Diagnostics(OTC) VPTDF

Market Cap$13.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-97%
5 Year-76%
1 Year-15%
1 Month-11%
$0.07
-1.79%
-0.00Today
Ventripoint Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 0.072026-08-27
Ventripoint Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.94%USD 0.072026-08-20
1 month-10.85%USD 0.082026-07-28
3 month-22.7%USD 0.092026-05-29
Year to date-31.58%USD 0.102025-12-31
1 year-15.26%USD 0.082025-08-27
3 year-64.95%USD 0.202023-08-28
5 year-76.03%USD 0.302021-08-27
Since inception-96.67%USD 2.152011-10-17

Ventripoint Diagnostics Financials at a Glance

Market Cap

$13.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$179.92K

Net Income (TTM)

-CA$3.20M

EPS (TTM)

-$0.01

P/E Ratio

-5.14

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$0.07

Volume

70

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.06 - $0.14

Estimated Earnings Date

Aug 27, 2026

VPTDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

VentriPoint Diagnostics Ltd. is a medical technology company focused on developing diagnostic tools for assessing cardiac conditions. The company’s flagship product, the VentriPoint Medical System (VMS), utilizes advanced imaging technology to create accurate three-dimensional models of the heart, enhancing diagnostic capabilities for various heart diseases.

Products and Services
  • VentriPoint Medical System (VMS) for cardiac imaging
  • VMS+ software for precise heart chamber modeling
  • Applications targeting congenital heart defects and cardiotoxicity
Growth Outlook
  • Expansion into diverse imaging techniques for heart disease diagnostics
  • Increasing demand for advanced cardiac assessment tools globally
  • Focus on developing solutions for COVID-19 related cardiac complications
Financial Highlights
  • Recent quarterly revenue of CAD 4,300, indicating ongoing operational challenges
  • Trailing twelve months (TTM) revenue of CAD 430,000, reflecting a need for growth
  • Net income for the latest quarter was CAD -199,588, highlighting financial pressures
VentriPoint Diagnostics Ltd. operates in the healthcare sector, specifically within medical devices, and is headquartered in Toronto, Canada. The company aims to address significant gaps in cardiac diagnostics through innovative technology. Despite facing financial challenges, including negative net income and a low revenue base, the potential for growth in the cardiac diagnostics market remains substantial. The ongoing development of specialized applications and the increasing global focus on heart health present opportunities for future expansion. Investors may find interest in the company's unique offerings and its commitment to improving cardiac care through advanced technology.
AI Generated • Aug 15, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hugh MacNaught

Website

www.ventripoint.com

Headquarters

Toronto, ON M6P 1T4, CA

VPTDF Financials

Key Financial Metrics (TTM)

Gross Margin

82.94%

Operating Margin

-1889.37%

Net Income Margin

-1778.62%

Return on Equity

78.25%

Return on Capital

N/A

Return on Assets

-677.90%

Earnings Yield

-19.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

192.78M

Volume

70

Avg. Volume

110.12K

Financials (TTM)

Gross Profit

CA$153.29K

Operating Income

-CA$3.40M

EBITDA

-CA$3.33M

Operating Cash Flow

-CA$1.53M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.53M

Cash & ST Invst.

CA$55.34K

Total Debt

CA$2.60M

Ventripoint Diagnostics Performance Analysis

Ventripoint Diagnostics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 52,361N/A
20232023-12-31CAD 36,440-30.4%
20242024-12-31CAD 69,47190.6%
20252025-12-31CAD 128,76985.4%
Ventripoint Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31N/A
Q22025-06-30-100.0%
Q32025-09-30N/A
Q42025-12-31-95.9%
Ventripoint Diagnostics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.025.7%
20232023-12-31CAD -0.02-4.2%
20242024-12-31CAD -0.02-1.3%
20252025-12-31CAD -0.01-39.2%
Ventripoint Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3110.6%
Q22025-06-30-33.9%
Q32025-09-3043.0%
Q42025-12-3177.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$4.30K

N/A

Gross Profit

-CA$11.12K

-3.7%

Gross Margin

-2.59%

N/A

Market Cap

$13.78MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.59M

N/A

Employees

3

N/A

Net Income

-CA$199.59K

+81.2%

EBITDA

-CA$722.58K

+31.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$55.34K

-8.6%

Total Debt

CA$2.60M

+59.0%

Accounts Receivable

CA$132.88K

-47.1%

Inventory

CA$0.00

N/A

Long Term Debt

CA$115.27K

-45.7%

Short Term Debt

CA$2.50M

+75.5%

Return on Assets

-6.78%

N/A

Return on Invested Capital

84.96%

N/A

Free Cash Flow

-CA$598.88K

+16.9%

Operating Cash Flow

-CA$598.88K

+16.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NUMIFNuminus Wellness Inc.
$0.04+14.29%
ALRTFALR Technologies Inc.
$0.02+0.00%
ASAPFAurora Spine Corporation
$0.12-16.36%
LUFFFHerbal Dispatch Inc.
$0.03+14.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$225.49-0.01%
BITOProShares Trust - ProShares Bitcoin ETF
$10.70-0.01%
INTCIntel
$92.57+0.01%
QNRXQuoin Pharmaceuticals
$6.74+0.31%

Questions About VPTDF

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at $0.07 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between $0.06 and $0.14.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of CA$1.90M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported CA$40.41K in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services